SG11201707117SA - Ophthalmic composition - Google Patents

Ophthalmic composition

Info

Publication number
SG11201707117SA
SG11201707117SA SG11201707117SA SG11201707117SA SG11201707117SA SG 11201707117S A SG11201707117S A SG 11201707117SA SG 11201707117S A SG11201707117S A SG 11201707117SA SG 11201707117S A SG11201707117S A SG 11201707117SA SG 11201707117S A SG11201707117S A SG 11201707117SA
Authority
SG
Singapore
Prior art keywords
ophthalmic composition
ophthalmic
composition
Prior art date
Application number
SG11201707117SA
Inventor
Takanori Ohno
Masahiro Kawahata
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of SG11201707117SA publication Critical patent/SG11201707117SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201707117SA 2015-03-06 2016-03-04 Ophthalmic composition SG11201707117SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015045065 2015-03-06
PCT/JP2016/056861 WO2016143708A1 (en) 2015-03-06 2016-03-04 Ophthalmic composition

Publications (1)

Publication Number Publication Date
SG11201707117SA true SG11201707117SA (en) 2017-10-30

Family

ID=56880167

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201901426WA SG10201901426WA (en) 2015-03-06 2016-03-04 Ophthalmic composition
SG11201707117SA SG11201707117SA (en) 2015-03-06 2016-03-04 Ophthalmic composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201901426WA SG10201901426WA (en) 2015-03-06 2016-03-04 Ophthalmic composition

Country Status (7)

Country Link
JP (2) JP6716293B2 (en)
KR (1) KR102607126B1 (en)
MY (1) MY190393A (en)
PH (1) PH12017501567A1 (en)
SG (2) SG10201901426WA (en)
TW (2) TW202114648A (en)
WO (1) WO2016143708A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190068575A (en) * 2016-10-14 2019-06-18 이콤 메디칼 게엠베하 Establishment of ocular surface homeostasis, recovery and preservation method
JP6603785B2 (en) * 2017-12-08 2019-11-06 千寿製薬株式会社 Aqueous solution containing water-soluble polymer
JPWO2021132609A1 (en) * 2019-12-27 2021-07-01
CN112870216A (en) * 2021-01-29 2021-06-01 张宽才 Pharmaceutical composition, preparation and application
JP2023022569A (en) * 2021-08-03 2023-02-15 小林製薬株式会社 Eyewash composition
CN114391550B (en) * 2022-01-06 2022-11-22 江南大学 Water-soluble chlorhexidine antibacterial agent and preparation method and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1072376A (en) * 1996-09-02 1998-03-17 Ofutekusu:Kk Eye drop aqueous solution comprising hyaluronic acid
JPH1160505A (en) * 1997-05-20 1999-03-02 Senju Pharmaceut Co Ltd Antiseptic composition
JPH115744A (en) * 1997-06-16 1999-01-12 Toa Yakuhin Kk Aqueous solution preparation for external use containing hyaluronic acid
JP2002193815A (en) * 2000-12-25 2002-07-10 Ophtecs Corp Eye drops for prevention of corneal drying for ophthalmic operation
JP2003002837A (en) * 2001-06-21 2003-01-08 Lion Corp Composition for aqueous skin care preparation and method for preventing clouding of liquid composition
JP4431817B2 (en) 2002-03-08 2010-03-17 第一三共株式会社 Eye drops containing tetrazole derivatives
JP4694773B2 (en) * 2003-06-06 2011-06-08 ロート製薬株式会社 Mucosal liquid composition
BRPI0515191A (en) * 2004-08-13 2008-07-08 Angiotech Internac Ag pharmaceutical composition, method for augmenting bone or replacing bone loss, method for reducing pain associated with postoperative scarring, method for preventing surgical adhesion, method for enlarging or repairing skin or tissue, method for maintaining eye fluid volume during eye surgery , method for reducing pain associated with osteoarthritis, method for treating gastroesophageal reflux disease, method for treating or preventing urinary incontinence, method for treating or preventing fecal incontinence, implant method and medical device
CN101528239B (en) 2006-10-26 2013-03-13 千寿制药株式会社 Ophthalmic aqeous liquid preparation
JP5595206B2 (en) * 2009-09-30 2014-09-24 ロート製薬株式会社 Ophthalmic liquid composition
WO2012176865A1 (en) * 2011-06-23 2012-12-27 参天製薬株式会社 Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol

Also Published As

Publication number Publication date
WO2016143708A1 (en) 2016-09-15
KR20170122773A (en) 2017-11-06
SG10201901426WA (en) 2019-03-28
MY190393A (en) 2022-04-20
PH12017501567A1 (en) 2018-02-05
TWI745287B (en) 2021-11-11
KR102607126B1 (en) 2023-11-27
JP6716293B2 (en) 2020-07-01
JP2020138979A (en) 2020-09-03
TW201705948A (en) 2017-02-16
JP2016166195A (en) 2016-09-15
TW202114648A (en) 2021-04-16

Similar Documents

Publication Publication Date Title
IL249643A0 (en) Ophthalmic composition
HK1244689A1 (en) Aqueous ophthalmic composition
GB201512030D0 (en) Composition
PL3373973T3 (en) Ocular compositions
GB201505527D0 (en) Composition
PT4082531T (en) Ophthalmic suspension composition
GB201506827D0 (en) Composition
SG11201707117SA (en) Ophthalmic composition
GB201506829D0 (en) Composition
GB201506830D0 (en) Composition
GB201506825D0 (en) Composition
GB201506828D0 (en) Composition
GB201511697D0 (en) Composition
GB201509044D0 (en) Composition
GB201505520D0 (en) Composition
GB201504665D0 (en) Composition
GB201504307D0 (en) Composition
GB201619525D0 (en) Ophthalmic composition
GB201508722D0 (en) Composition
GB201506826D0 (en) Composition
ZA201703701B (en) Ophthalmic composition
PL3446682T3 (en) Ophthalmic composition
IL251590B (en) Ophthalmic compositions
GB201509641D0 (en) Composition
PT3470059T (en) Ophthalmic suspension composition